Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Oncotarget|December 22, 2017
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agentBernadette V Marquez-Nostra, Supum Lee, Richard Laforest, et al.
Chemical Reviews|October 28, 2025
Chemical Tools to Characterize the Coordination Chemistry of Radionuclides for Radiopharmaceutical ApplicationsEszter Boros, Peter Comba, Jonathan W Engle, et al.
Nature|January 9, 2019
The surprisingly large neutron capture cross-section of 88ZrJennifer A Shusterman, Nicholas D Scielzo, Keenan J Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2025
Quantitative [89Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRIAmeer Mansur, Jonathan E McConathy, Erica Stringer-Reasor, et al.
Nuclear Medicine and Biology|March 9, 2026
Spatial resolution and image quality of radionuclides for PET imagingSharon L Samuel, Solana Fernandez, Shelbie J Cingoranelli, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 9, 2015
Investigating the pharmacokinetics and biological distribution of silver-loaded polyphosphoester-based nanoparticles using (111) Ag as a radiotracerTolulope A Aweda, Shiyi Zhang, Chiedza Mupanomunda, et al.
Breast Cancer Research and Treatment|February 15, 2018
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancerFarrokh Dehdashti, Ningying Wu, Ron Bose, et al.
Scientific Reports|November 28, 2020
Novel multimodal molecular imaging of Vitamin H (Biotin) transporter activity in the murine placentaNoam Ben-Eliezer, Marina Lysenko, Inbal E Bilton, et al.
Angewandte Chemie (International Ed. in English)|March 9, 2022
A General Design Strategy Enabling the Synthesis of Hydrolysis-Resistant, Water-Stable Titanium(IV) ComplexesAngus J Koller, Shefali Saini, Ivis F Chaple, et al.
Scientific Reports|February 15, 2024
Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCCPatrick N Song, Shannon E Lynch, Chloe T DeMellier, et al.
Pageof 17